Ingevity (NGVT) reported Q4 adjusted earnings late Tuesday of $0.95 per diluted share, compared with a loss of $0.20 a year earlier.
Four analysts polled by FactSet expected non-GAAP EPS of $0.31.
Net sales in the three months ended Dec. 31 fell to $298.8 million from $371.7 million a year earlier.
Three analysts surveyed by FactSet expected $310.9 million.
The company expects 2025 sales of $1.3 billion to $1.4 billion.
Four analysts surveyed by FactSet project $1.45 billion.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。